Westaim Corporation (The) - Sales Analysis Snapshot

Business Description
This Report provides a comprehensive Sales & Margin summary analysis for Westaim Corporation (The) Tabular results include up to a ten-year history on Sales, EBITDA (Earnings before Interest, Taxes, Depreciation and Amortization), Income before Extraordinary Items and number of Employees. Additional ratios are included for sales growth, earnings and income as a percent of sales and Sales per Employee.

Westaim Corporation (The). The Group's principal activities are to develop, manufacture and commercialize medical products that fight infection and inflammation. The Group operates through two segments: NUCRYST Pharmaceuticals and iFire Technology. NUCRYST Pharmaceuticals segment researches, develops and commercializes wound care products and pharmaceutical products based on noble metal nanocrystalline technology. iFire Technology segment develops proprietary flat-panel full color solid-state display technology. The Group operates in Canada, the United States and Europe.

Not the Report you are looking for? Click here for more browsing options.

view sample Single Report

view sample All Basic Reports

Layout and Content of a Typical Report